Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2022.
The company has reported fall of 5.57% in its net profit at Rs 486.73 crore for Q3FY23 as compared to Rs 515.43 crore for the corresponding quarter previous year. However, total income of the company increased by 15.65% to Rs 4,713.78 crore for the quarter under review as compared to Rs 4,075.89 crore for the same quarter in the previous year.
On the consolidated basis, the company has reported rise of 2.69% in its net profit at Rs 2,188.04 crore for Q3FY23 as compared to Rs 2,130.80 crore for the same quarter in the previous year. However, total income of the company increased by 10.87% to Rs 11,414.85 crore for the quarter under review as compared to Rs 10,295.57 crore for the same quarter in the previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1785.00 |
Dr. Reddys Lab | 1355.00 |
Cipla | 1475.25 |
Lupin | 2185.50 |
Zydus Lifesciences | 1003.00 |
View more.. |